Trial Profile
ETUDE DE LA PHARMACOCINETIQUE DE L'ASSOCIATION PIPERACILLINE - TAZOBACTAM EN UTILISATION INTRA-VEINEUSE CONTINUE CHEZ L'ENFANT NEUTROPENIQUE FEBRILE .
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Febrile neutropenia
- Focus Pharmacokinetics
- 24 Aug 2011 New trial record